ATI’s Bioscience Director, Jessica Hanover, Departs for Private Sector Opportunity

Share Article

The Austin Technology Incubator (ATI), a not-for-profit arm of The University of Texas at Austin, is excited to announce that Jessica Hanover, Ph.D., ATI’s inaugural Bioscience Director, will be leaving to take a position with Rules-Based Medicine (RBM), an Austin-based CLIA-certified biomarker testing laboratory that solves complex therapeutic development, diagnostic and treatment challenges with innovative products and services.

The Austin Technology Incubator (ATI), a not-for-profit arm of The University of Texas at Austin, is excited to announce that Jessica Hanover, Ph.D., ATI’s inaugural Bioscience Director, will be leaving to take a position with Rules-Based Medicine (RBM), an Austin-based CLIA-certified biomarker testing laboratory that solves complex therapeutic development, diagnostic and treatment challenges with innovative products and services.

Following her roles in biotechnology equity research and medical device strategy, Hanover started as ATI’s first Bioscience Director in August 2008, after the Bioscience program was launched with a $125,000 grant from the city of Austin. She has been responsible for identifying promising early-stage companies that are developing technologies relevant to the life sciences space, including drug therapies, medical devices, diagnostics, and research tools, and she is credited with admitting four early-stage bioscience companies into ATI: Savara, Minimus Spine, Infinagen, and a new company focusing on digital pathology. She has also supported previously-admitted ATI-Bioscience member companies Terapio and Agile Planet. During Hanover’s tenure with ATI, Bioscience member companies raised approximately $8 million in funding, allowing them to achieve important company milestones.

Hanover also helped to build the Central Texas bioscience infrastructure of investors, entrepreneurs, clinicians, scientists, and engineers. In 2009, in partnership with the Austin chapter of the Rice Alliance, ATI-Bioscience launched “symBIOsis,” a life sciences networking and educational panel series, the first of its kind in Austin. Hanover has also collaborated with the science and engineering communities within UT-Austin, helping to create avenues for commercialization of bioscience technology. In addition, under Hanover’s direction, ATI has helped coordinate efforts to expand access to wet lab facilities in Central Texas. An avid cyclist, Hanover organized ATI’s Tech Riders cycling team and helped raise $6500 for the Texas Mamma Jamma Ride and non-profit agencies supporting breast cancer patients, in honor of a colleague affected by breast cancer.

“ATI has provided me with the unique opportunity to partner with Austin’s growing bioscience community, with which I will continue to be involved, ” said Hanover. “I’m always impressed by the dedication of our bioscience entrepreneurs, striving to bring new and more effective technologies to physicians and patients, and I’m excited to have the chance to do the same with Rules-Based Medicine, here in Austin.”

“Jessica has done a terrific job building up ATI’s Bioscience program,” said Isaac Barchas, ATI’s overall Director. “And she is going to a very exciting position at RBM, which will further strengthen life sciences in Austin. At ATI, we incubate people as well as companies, and this is a great ‘graduation’ for Jessica!”

About Austin Technology Incubator
The Austin Technology Incubator is a nonprofit unit of The University of Texas at Austin that harnesses business, government and academic resources to provide strategic counsel, operational guidance and infrastructure support to its member companies to help them transition from early stage ventures to successful technology businesses. Since its founding in 1989, ATI has worked with over 200 companies, helping them raise close to $750 million in investor capital. ATI is a key program of the IC2 Institute at The University of Texas at Austin. For more information, visit http://www.ati.utexas.edu.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Melissa Rabeaux
Visit website